Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fast, Cheap, and Easy Testing Method Could Become a Game-Changer in Antibiotic Sensitivity Testing

By LabMedica International staff writers
Posted on 26 Apr 2023
Print article
	Image: Testing antibiotic resistance with a fast, cheap, and easy method (Photo courtesy of EPFL)
Image: Testing antibiotic resistance with a fast, cheap, and easy method (Photo courtesy of EPFL)

Antibiotic resistance, which has become a critical global public health issue, occurs when bacteria evolve to withstand the drugs designed to eliminate them. Antibiotic sensitivity testing (AST) typically involves culture or genetic methods to determine bacterial resistance. Conventional ASTs can take up to 24 hours or longer for slow-growing bacteria, a critical period in clinical settings. Although faster ASTs have been developed, they often require complex and costly equipment. Researchers have now created a rapid, affordable, and accessible method based on optical microscopy that can perform AST at the single-cell level without needing to attach or label bacteria. The technique utilizes a standard optical microscope, a camera or mobile phone, and specialized software.

The new technique developed by researchers at EPFL (Lausanne, Switzerland) and Vrije Universiteit Brussel (Brussels, Belgium) is called optical nanomotion detection (ONMD) and monitors the nanoscale vibrations of individual bacteria before and during antibiotic exposure. Monitoring is performed using a basic optical microscope and a video camera or mobile phone. ONMD observes the microscopic oscillations (nanomotion) of bacterial cells, which signify living organisms and serve as a "signature of life." Nanomotion persists as long as the organism is alive, ceasing immediately upon death. In ONMD, bacterial nanomotion is captured in a video where individual cell movements are monitored with sub-pixel resolution.

Researchers successfully applied ONMD to detect the sensitivity of various bacteria to antibiotics, determining the sensitivities of Escherichia coli, Staphylococcus aureus, Lactobacillus rhamnosus, and Mycobacterium smegmatis (a non-pathogenic bacterial model for tuberculosis) sensitivities to antibiotics like ampicillin, streptomycin, doxycycline, and vancomycin in under two hours. ONMD not only tracks bacteria's life-death transitions upon antibiotic exposure but also reveals changes in bacterial metabolism due to nutrient availability. Tests demonstrated that ONMD can quickly and simply evaluate bacterial sensitivity or resistance to antibiotics by monitoring cellular oscillations. The researchers believe that the method's simplicity and effectiveness make it a game-changer in AST, with far-reaching implications for clinical and research applications, as it can be applied to a wide variety of bacteria.

“We have developed a technique in our laboratories that allows us to obtain an antibiogram within 2-4 hours – instead of the current 24 hours for the most common germs and one month for tuberculosis,” said Dr. Sandor Kasas at EPFL.

“Our technique is not only faster but also simpler and much cheaper than all those existing now,” added Professor Ronnie Willaert at Vrije Universiteit Brussel.

Related links:
EPFL
Vrije Universiteit Brussel

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.